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Fluoride varnish production and use has had a dramatic increase in the 
last decade following approval by the FDA in 1994 as a cavity liner and root 
desensitizer.1 Despite its "off-label" use in caries prevention, research has 
demonstrated varnishes to be a safe, effective, and efficient way to deliver 
fluoride to patients at risk for dental caries.2,3 Accordingly, fluoride 
varnishes are widely recommended for patients at high risk for dental caries 
(ADA, CDC, AAPD). Although the FDA did not approve fluoride varnishes 
until 1994, the first fluoride varnish was developed in the 1960's as a 
possible mechanism to enhance the treatment duration and uptake of 
fluoride.4 Most of the clinical research on fluoride varnishes has been 
conducted using Duraphat (5% NaF), which was the first commercially 
available product. Within the last few years, numerous varnishes with 
similar sodium fluoride concentrations (5%), but with multiple variations in 
carrier composition, have emerged and have taken a significant portion of 
the market share. As the number of fluoride varnishes available has 
increased, each company has created unique changes to the formula in order 
to improve properties like handling, appearance (i.e., white), flavor, or in 
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some cases, potentially active ingredients (e.g., tricalcium phosphate, 
amorphous calcium phosphate, calcium sodium phosphosilicate, xylitol, 
etc.),5,6,7,8 leading to a claim of additional preventive benefits. Most of these 
new varnishes have not been studied in vivo for their caries reduction, 
efficacy, or safety. 
Despite the similar 5% NaF concentration used in most of these 
varnishes, in vitro data have suggested that some of these secondary 
ingredients may affect the fluoride ion release of the product.9,10,11 Fluoride 
release, and subsequent formation of calcium fluoride is thought to be an 
essential part of the mechanism of action of fluoride varnishes to prevent 
and remineralize carious lesions. Differences in fluoride release patterns can 
potentially enhance or diminish the efficacy and safety of a varnish. 
Therefore, understanding the differences in fluoride release pattern of 
varnishes with different formulations in vivo will help us understand which 
formula modifications have the potential to enhance or diminish the 
anticariogenicity and safety of the varnish. Several studies have compared 
fluoride varnishes to other delivery systems such as gels, foams, and pastes; 
however, a void remains in the literature regarding the comparison of 
efficacy and safety between the many different new fluoride varnish systems 
containing 5% NaF widely available today in the US market.   
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The fluoride varnishes to be used in this study were chosen based on 
their unique characteristics. Duraphat (Colgate-Palmolive) was chosen 
because it has the largest body of laboratory and clinical research and it is 
considered the gold standard. Vanish (3M ESPE) was chosen because it is 
relatively new, has a large portion of the market share for varnishes, uses a 
different resin formulation, and contains tri-calcium phosphate. The third 
varnish, Enamel Pro (Premier) was selected because it is also very popular, 
has amorphous calcium phosphate added, and in laboratory studies it has 
shown to release significantly more fluoride than the other two 
varnishes.9,10,11 
Comparison of the material safety data sheets for each of these 
different varnishes reveals three similar ingredients, namely rosin 
(colophonium), ethanol, and sodium fluoride. However, according to the 
Hazard Communication Standard 29 CFR 1910.1200 developed by OSHA, 
only those ingredients that may be hazardous require documentation and 
therefore many of the unique formulary ingredients of fluoride varnishes 
remain undisclosed.12 These ingredients, called "trade secrets" by OSHA, 
may be withheld from MSDS reports when they are deemed non-hazardous 
and create some advantage to a company over other companies that do not 
know of it or use it. Some early investigations have suggested that the 
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addition of calcium phosphate ingredients used in some dental products may 
increase both fluoride release from products and subsequent uptake of 
fluoride in enamel.13,14 By evaluating the fluoride release from these three 
varnishes, each containing different calcium phosphate compounds and other 
ingredients, some insight may be gained as to the complex interaction of 
these trade secrets and the effect they may have on fluoride varnish efficacy.  
Purpose 
Determine and compare the fluoride concentration in unstimulated whole 
saliva at five different time periods following the application of three 
different 5% NaF varnishes.   
Hypotheses 
Ho1 - There will be no significant difference in the amount of fluoride 
release into saliva among the 3 different varnishes.  
Ha1 – There will be a significant difference in the amount of fluoride release 
into saliva release among the 3 different varnishes. 
Ho2 – There will be no significant difference in the timing of fluoride 
release in to saliva among the 3 different varnishes. 
Ha1 – There will be a significant difference in the timing of fluoride release 
into saliva among the 3 different varnishes. 
 5 
Specific Aims 
1. Determine the concentration of fluoride available in whole saliva at 
different time periods after the application of three different 5% NaF 
varnishes as measured in unstimulated human saliva. 
2. Compare the different patterns of fluoride release from each of the 
varnishes by comparing the fluoride concentration in saliva at 




Fluorine is the 13th most prevalent element and is found in water air 
and soil. Fluoride, which is the ionic form of the element fluorine, is a 
negatively charged ion that frequently combines with positive ions to form 
more stable compounds.15 The discovery of fluoride and its relevancy to 
dentistry in t he United States, dates back to 1901.16 According to the 
National Institute of Dental and Craniofacial Research (NIDCR), it began 
when Dr. Frederick McKay discovered brown staining on the teeth of 
Colorado Springs, CO natives. He could not find any mention of this 
condition in the current literature in 1909, so with the collaborative help of 
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G.V. Black he was able to make two important discoveries. First, only 
children with mottled deciduous teeth suffered from a similar mottled 
appearance of their adult teeth, and second, individuals with mottled teeth 
were very resistant to dental caries. In 1931, the connection between tooth 
mottling and naturally occurring high fluoride concentration in water was 
revealed. In 1945, Grand Rapids Michigan became the first community to 
have its water fluoridated and after 11 years they reported a 60% decrease in 
caries rate in children born after the fluoridation implementation began.  
According to the 2001 Morbidity and Mortality Weekly Report1, 
success following this water fluoridation initiation prompted the Public 
Health Service (PHS) to develop recommendations in the late 1940’s and 
1950’s regarding community water fluoridation, and later, the development 
of fluoride-containing products. With the transition from water fluoridation 
to fluoride containing topical preparations, scientists began to inquire and 
study the difference between the systemic versus topical effects of fluoride. 
According to a review by Limeback17 this question was still not 
satisfactorily answered by the literature in the late 1990's. The initial thought 
was that by evaluating the differences in the caries rate of adults that 
received systemic fluoride before the age of six, an estimation of the 
protective effects of systemic fluoride could be measured separately from 
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the topical effects seen in populations that did not receive systemic fluoride 
but were later exposed to fluoride containing topical applications. Systemic 
effects such as favorable changes in tooth morphology, and fluoride 
incorporation into enamel have been hypothesized. As Limeback points out, 
however, it is difficult to positively say that ingested fluoride is not also 
acting topically if its introduction to the system is through an oral route as in 
the case of water. The mechanism of action of topically applied fluorides is 
not as clear cut either and is still the subject of numerous studies. To 
accurately answer the question of how effective and by what mechanism do 
topical and systemic fluorides work, additional controlled studies need to be 
conducted. Currently, the prevailing evidence points to topical or post-
eruptive fluoride administration as the primary means of caries reduction. In 
1954, fluoride containing dentifrices became available in the U.S. followed 
by higher fluoride containing preparations of rinses, gels, and varnishes.18  
The introduction of fluoride varnish in the dental literature came in 
1964 as a report by a German researcher named Schmidt.4 The journal, 
Stoma, introduced "Fluor-Lack" (fluoride lacquer) as a long-lasting fluoride. 
Four years later Schmidt and Heuser19 published the first clinical trial on the 
efficacy of this varnish and launched it as a commercial product under the 
name Duraphat (Rhone-Poulenc Rorer, Rorer GmbH Köln, Germany). 
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Following clinical studies related to the efficacy and safety of Duraphat, 
other varnishes for topical fluoride application started to become available. 
Fluor Protector (0.7% F- at a low pH) was developed in 1975 by Arends and 
Schuthof (changed to 0.1% F- in 1987).20 In 1984 Pharmascience Inc. 
developed a 5% NaF Varnish called Duraflor/Durafluor (personal 
communication 2012), and shortly after in 1986 VOCO developed a 6% 
NaF, 6% CaF varnish called Bifluorid 12.21 Today Duraphat is marketed in 
the USA by Colgate-Palmolive, Fluor Protector by Ivoclar/Vivadent and 
Duraflor by Medicom. In 1994 the FDA approved fluoride varnishes for use 
as a cavity liner and root desensitizer, however it is primarily been the "off-
label" use in caries prevention that has led to the development of the 
numerous brand names available today.3 
In 2006 evidence-based clinical recommendations for topical fluoride 
were published by the American Dental Association (ADA)22. Following a 
Cochrane Systematic Review on clinical studies involving fluoride gels, 
foams, and varnishes, recommendations for topical fluoride application 
accounting for caries risk level and age were published. The strongest 
evidence was shown for topical varnish use in caries prevention in moderate 
to high risk patients, ages < 6 and 6-18 years, to be applied at either 6 
(moderate risk) or 3 (high risk) month intervals. These recommendations for 
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topically applied fluoride by the ADA are in agreement with the 2008 
revised Guideline on Fluoride Therapy by the American Academy of 
Pediatric Dentistry (AAPD).22 
Composition 
Interestingly, determining the exact composition of each fluoride 
varnish is not possible because, according to the Hazard Communication 
Standard 29 CFR 1910.1200 developed by OSHA12, only those ingredients 
that may be hazardous require documentation. Therefore, many of the 
unique proprietary components of fluoride varnishes remain undisclosed. 
These ingredients, called "trade secrets" by OSHA, may be withheld from 
Material Safety Data Sheets (MSDS) when they are deemed non-hazardous 
and create some advantage to a company over other companies that do not 
know of it, or use it. 
Although the original formulations have changed over time, the 
current MSDS of the first three commercially available fluoride varnishes in 
the United States list the following active ingredients; both Duraphat 
(Colgate -Palmolive) and Duraflor (Medicom) contain 5% NaF with a rosin 
and ethanol carrier.5,6 Fluor Protector (Ivoclar-Vivadent), differs from the 
others in the use of difluorosilane as the fluoride source. Fluor Protector, 
according to the product information guide,20 and MSDS,7 contains 0.9% 
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difluorosilane in a polyurethane varnish base with ethyl acetate and 
isoamylpropionate solvents.  
Comparing the MSDS of several commercially available varnishes it 
is apparent that, with only a few exceptions, the main constituents are quite 
similar. The common constituents of most varnishes available today are 
rosin, also referred to as colophony (either natural or synthetic), an alcohol, 
and sodium fluoride. The amount of each product is estimated on the MSDS, 
however most of the current top market varnishes advertise 5% neutral 
sodium fluoride as the active ingredient. This percentage is likely based 
upon the formulation of the first varnish, Duraphat, which has been 
extensively studied and boasts a 38% caries reduction in permanent dentition 
according to meta-analysis.23 
 Rosin, as defined by Merriam-Webster is "a translucent amber-
colored to almost black brittle friable resin that is obtained from the 
oleoresin or deadwood of pine trees or from tall oil and used especially in 
making varnish".24 Fluoride salts which are commonly referred to simply as 
fluorides, according to the U.S. Department of Health and Human Services, 
are naturally occurring components of rocks and soils.15 A 5% concentration 
of sodium fluoride will contain 2.26% of the fluoride ion (22,600 ppm). 
Therefore, in a typical single dose varnish preparation of 0.4 ml, there are 
 11 
potentially 9 mg of fluoride available in the oral cavity after application. 
Ethanol or other alcohols are used as solvents that are intended to evaporate 
from the solution once exposed to air allowing for the varnish to be fluid 
enough for application but then become adherent to enamel surfaces for 
increased length of fluoride exposure.  
In addition to these three main constituents, other additives may be 
present such as an adhesion promoting agents, stabilizing agents, rheology 
modifying agents, colorants, sweeteners, and flavoring agents.8 Recent 
trends, in lieu of data that support the need for calcium and phosphate ions to 
aid in remineralization and inhibit demineralization, have led to the addition 
of calcium phosphate compounds to some fluoride varnishes. For example 
enamel Pro (Premier Dental) markets the addition amorphous calcium 
phosphate (ACP), while Vanish (3M ESPE) uses tri-calcium phosphate 
(TCP) in its formulation. While theoretically these additions are included to 
enhance the product efficacy, the addition of these secondary ingredients 
may have profound influence on the amount, or pattern of fluoride ion 
release. 
Mechanism of Action 
In order to understand how fluoride varnishes are utilized in caries 
prevention, it is first important to review the mechanism of action of topical 
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fluoride in general. In 1999 Øgaard discussed possible mechanisms in h is 
review, The Cariostatic Mechanism of Fluoride.25 Originally, it was 
believed that the most important aspect of caries protection from fluoride 
was the systemic ingestion that resulted in fluoride being built into the 
structure of enamel during tooth formation causing reduced solubility of the 
apatite crystal. However, it is now widely accepted that the main mechanism 
of action of fluoride is to pical. Effects such as the inhibition of bacteria, 
reduction of demineralization, and increased remineralization have been the 
focus of current studies. According to Øgaard, available fluoride may 
exchange F- for OH-, promote crystal growth of fluorapatite, or produce 
calcium fluoride.  
Bacterial Inhibition 
 In 2007, Jeevarathanet al.26 developed a study to t he see if Fluor 
Protector (Ivoclar, Vivadent) varnish had an effect on the counts of 
Streptococcus mutans in the plaque of caries free children. They used thirty 
subjects that were separated into a study group of twenty and a control group 
of ten. Plaque was obtained from similar surfaces of each subject’s teeth. 
Baseline samples were obtained for both the study and control group. The 
study group then had Fluor Protector applied to clean surfaces of all teeth. 
After plaque collection 24 hours post varnish application, and incubation for 
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48 hours, the levels of S. mutans were determined using Dentocult SM Strip 
Mutans (Orion Diagnostica, Espoo, Finland). They demonstrated a 
significant reduction in plaque of the bacteria S. mutans (p=0.000). This 
study supports the hypothesis that topical fluoride may have bactericidal or 
bacteriostatic effects. The study did not address the potential that varnish 
application simply blocked the adherence of S. mutans to the enamel 
surfaces of the sampled areas.  
 Pandit et al.27 studied the influence of sodium fluoride on the 
virulence and composition of S. mutans biofilms to determine if perhaps one 
of the mechanisms of action of fluoride was directly on the bacteria. In this 
study, they utilized S. mutans exclusively to determine what effects NaF at 
10, 50, and 125 ppm would have on S. mutans biofilm cells. S. mutans 
biofilms were formed on saliva coated hydroxyapatite discs, transferred to a 
1% solution of sucrose and given 74 hours to grow and develop. The biofilm 
discs were treated twice daily with a control (100% H2O) or NaF (2, 10, 50, 
and 125 ppm). Following the experimental phase they evaluated glycolytic 
pH drop, proton-permeability, F-ATPase activity, GTF activity, and biofilm 
composition. They determined that NaF significantly reduced the initial rate 
of pH drop at concentrations of 10, 50, and 125 ppm, and that the pH change 
was NaF dose dependent. Additionally proton permeability was enhanced, 
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and F-ATPase activity was reduced in the S. mutans biofilm cells at 50 and 
125 NaF ppm, which both serve to regulate pH homeostasis within the 
bacterial cells. Despite some of their other findings, at the concentration of 
NaF used in this study there were no bactericidal  activity against S. mutans, 
and the controls displayed similar amounts of CFU's indicating no growth 
rate inhibition. Overall, this study provided evidence that sodium fluoride 
may alter the acid production and acid tolerance of S. mutans in biofilms. 
One of the major shortcomings of this experiment was the lack of diversity 
within the experimental biofilm. It is possible that in vivo interactions 
between different types of bacteria may significantly alter these results.  
 A study done by Zickert et al.28 supported the findings by Pandit, that 
increased fluoride may not act by eliminating or reducing the actual amounts 
of S. mutans, but rather the increased fluoride may inhibit metabolic 
activities of the bacteria. This in vivo study used 40 children that were pair-
matched for baseline salivary levels of S. mutans. Each group participated in 
the experimental and control arm of the study. The design consisted of two 
experimental arms. In experiment one, participants had 0.5 ml of 5% NaF 
(Duraphat) varnish applied to professionally cleaned teeth and were not able 
to eat for 3 hours or brush for the remainder of the day. In the second arm, 
participants had the same treatment varnish applied, however it was applied 
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to teeth without prior prophylaxis. Results showed that there was no 
significant reduction in the proportion of S. mutans in the saliva of either 
experimental group when compared to the control at 4, 10 or 21 days after 
the treatment. They hypothesized that it may not have been an adequate 
concentration to be bactericidal, since some other studies have been able to 
show a reduction in total bacteria. They did not evaluate salivary bacteria 
levels during the time frame in which the fluoride varnish concentration 
would have been the highest in the saliva, however seeing a significant 
reduction in a microorganism within hours of varnish application was 
thought to be unlikely.  
Fluorapatite Production 
 In 1984 Øgaard et al.29 investigated the retention of fluoride in sound 
and demineralized dentin after treatment with Duraphat 5% NaF. Their aim 
was to determine if the prophylactic effect of fluoride was in the formation 
of fluorapatite (alkali insoluble fluoride) or in the formation of alkali soluble 
CaF2. Using paired premolars indicated for extraction for orthodontics, they 
evaluated the effect fluoride had on so und enamel (ten pairs), and 
demineralized enamel (eight pairs). To create the demineralized enamel 
group, individuals had orthodontic bands placed on the premolars that 
allowed for plaque accumulation for 4 w eeks before the Duraphat 
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application. For the sound enamel samples, the premolar pairs had 
immediate application of the Duraphat. All teeth were extracted two weeks 
after the varnish was applied. Using an acid etch technique to r emove 
enamel at 3 different layers, the samples were then exposed to KOH 
removing all loosely bound fluoride (CaF2, or KOH s oluble fluoride), 
leaving, presumably the KOH insoluble fluoride (fluorapatite). Using a 
fluoride selective electrode to measure the amount of fluoride, and atomic 
absorption spectroscopy to measure calcium in the samples, the control teeth 
were compared to the experimental teeth for amounts of CaF2 vs. 
fluorapatite. It was found that in the sound enamel, total fluoride content was 
greatest in the most superficial layer, and that the majority of the fluoride 
increase was accounted for by the formation of CaF2 (≥ 52%) as opposed to 
fluorapatite (≤ 16.6%). Additionally, the demineralized samples retained 
more fluoride in all three layers, and in the deeper layers, fluorapatite 
contributed to as much as 75% increase in the fluoride content. This study 
demonstrated two possible ways fluoride accumulates in high fluoride 
environments, and how it is possible that different environments 
(demineralized vs. sound enamel) may impact this interaction.  
 In 1992 Cruz et al.30 evaluated the uptake of KOH-soluble and KOH-
insoluble fluoride in enamel after the application of Duraphat or a 2% NaF 
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solution. The purpose of this study was to quantify the amount of apatitically 
bound fluoride in contrast to the loosely bound fluoride after the use of two 
neutral sodium fluoride preparations. Using surgically extracted impacted 
third molars a 2.5 mm surface area of enamel was exposed to either a 2% 
NaF solution, pH 7.5, for 5 minutes, a 5% NaF Duraphat varnish for 5 
minutes, or left untreated. Both samples were rinsed of the fluoride after the 
5-minute testing period. Samples were then subjected to removal of the 
alkali-soluble fluoride by using 1M KOH which removed both calcium 
fluoride like material, and adsorbed fluoride. Following the removal of 
loosely bound fluoride, the KOH-insoluble or apatitically bound F was 
removed by etching three successive layers and analyzing each layer for 
fluoride. Results from this study showed that untreated samples showed 
traces of alkali-soluble fluoride. The samples exposed to 2% NaF solution 
had the greatest amount (13x) of loosely bound fluoride in comparison to the 
5% NaF varnish. Neither groups showed any increase in apatitically bound 
fluoride during the treatment period. The authors suggested that this type of 
fluoride incorporation may only occur after pH cycling in plaque. This may 
also support the hypothesis that it is the loosely bound calcium fluoride that 
is of greatest importance in the mechanistic action of high fluoride rinses 
and varnishes. It was interesting to find that impacted third molars had 
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soluble CaF2 present on t heir surfaces. This may indicate that teeth are 
exposed topically to some amount of fluoride even before eruption.   
 Grobler and Kotze31 evaluated the difference in loosely bound alkali-
soluble fluoride and insoluble fluoride by observing the relative amounts of 
each found in erupted and unerupted third molars. This study was novel 
because the subjects used in this study had minimal levels (<0 .1 ppm) of 
water fluoridation during ages 1-16, but did have exposure to daily tooth 
brushing. They evaluated 32 erupted and 22 unerupted third molars removed 
for various reasons. 19 of the erupted third molars, and 11 of the unerupted 
third molars were unwashed, while 11 of erupted and 11 unerupted third 
molars were alkali washed. After their respective treatments, five successive 
acid-etch biopsies were obtained from specific cusp sites. Using a fluoride 
ion-selective electrode, the fluoride concentration of a buffered solution 
containing the etchings was determined. Additionally the Ca concentration 
was determined using N2O/C2H2 flame atomic absorption spectrometry. The 
results of this study indicated that for the first two etch depths, significant 
differences between the mean enamel fluoride concentrations could be found 
between unerupted unwashed versus washed teeth, and the erupted washed 
versus unwashed teeth. In both erupted and unerupted teeth, the amount of 
fluoride in enamel plateaued at about 20 µm into the tooth. In the erupted 
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tooth, there was an approximate 78% increase in fluoride content compared 
to the unerupted tooth in the first 3 µm , 53% of which was alkali-soluble or 
loosely bound, and 47% of which was in a firmly bound form. For the 
unerupted tooth, no loosely bound fluoride was found. This study indicates 
that fluoridated toothpaste does increase both the loosely bound and firmly 
bound fluoride in vivo. Additionally, the fact that they did not find any 
loosely bound fluoride in the unerupted teeth of this study population that 
did not have fluoridated water, would support the theory that the unerupted 
teeth in the study by Cruz, were somehow receiving topical fluoride from 
systemically ingested fluoride.  
Demineralization/Remineralization 
 According to Øgaard et al.,25 fluoride not only increases the rate of 
remineralization, but can be reprecipitated with calcium and phosphate ions 
onto the enamel surface. This benefit is mostly seen when there is a constant 
low-dose fluoride interaction such as water fluoridation. For concentrated 
fluoride agents such as varnishes, the mechanism may vary slightly. Øgaard 
states that these higher fluoride containing agents may “form an intermediate 
product of calcium fluoride on the tooth surface, in lesions, and in plaque.” 
Sometimes referred to as phosphate-contaminated calcium fluoride, these 
compounds can be seen under high magnification and may remain present 
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up to weeks after topical fluoride treatment. These globules which appear to 
be stabilized by phosphate, may act as fluoride reservoirs that have the 
ability to r elease fluoride when the pH is lowered. This fluoride released 
helps prevent the dissolution of calcium and phosphate from enamel, 
effectively enhancing the rate of remineralization and slowing 
demineralization. When the pH returns to normal, phosphates once again 
protect this calcium fluoride until the next drop in pH.   
In 1988, Seppä32 was evaluating this theory of remineralization as the 
primary mechanism of fluoride action by testing the ability of pre-softened 
enamel to remineralize with different concentrations and number of 
applications of sodium fluoride. In this study 5x5 mm slabs of noncarious 
human enamel were divided into six experimental groups. The groups were 
treated as follows; no treatment, 2.26% Duraphat on day 1, 2.26% Duraphat 
on days 1, 4, and 7, 1.13% Duraphat on day 1, 1.13% Duraphat on days 1, 4, 
and 7, or a 1 minute treatment with 0.1% NaF solution each of 9 days total. 
After 24 hours, the varnish was removed and reapplied as dictated by the 
different treatment groups. Samples were stored in artificial saliva that was 
renewed daily. Once daily the slabs were immersed in a lactic acid-NaOH 
buffer (ph 5.0) for 1 h our and then rinsed with water to simulate 
demineralization. Finally, the acid resistance and fluoride uptake was 
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measured by immersing the slab in the lactic acid-NaOH solution leaving a 
9.6mm2 area uncovered and determining the amount of dissolved calcium 
and fluoride. Vickers hardness was evaluated after pre-softening, after the 9-
day study period, and after the 1 hour demineralization. Results showed that 
all treatments were effective at preventing softening of enamel during the 9 
day study period. The three treatments with 2.26% Duraphat were slightly 
more effective than the rest of the varnish treatments, but not at a 
statistically significant level. The 0.1% NaF solution was the least effective 
at preventing softening of the enamel. Enamel treated three times with either 
2.26% or 1.1% fluoride showed the greatest acid resistance. Because the 
enamel remineralization was similar between the treatment groups receiving 
2.26% Duraphat one or three times, and the group receiving 1.1% Duraphat 
one or three times, the authors concluded that it is possibly not the 
concentration of fluoride that is most important, but rather the number of 
applications. In addition, because a single application of Duraphat 2.26% 
was able to promote remineralization during the whole 9-day period, it is 
possible that a formation of soluble CaF2 on the enamel surface was able to 
act as a fluoride reservoir during acidic challenges. Seppä found that 
although the higher varnish fluoride concentrations did result in an increased 
uptake of fluoride in enamel, the number of applications did not increase this 
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uptake in enamel. Enamel solubility was not directly proportional to the 
fluoride content of the enamel.  
In order to elucidate the effect that CaF2 may have on the inhibition of 
enamel demineralization, Tenuta et al.33 designed a double-blind, crossover, 
in situ study that evaluated how newly formed CaF2 on enamel could be 
released to an S. mutans test plaque fluid. Subsequently, this plaque fluid 
was then used to see the effect it would have on enamel following an acidic 
challenge. Distinct amounts of CaF2 were created on enamel slabs by either 
not treating them (control) or treating them with acidulated 0.5M NaF 
solution and aging the slabs in 6 ho urs, or 48 hours in artificial saliva. A 
representative group of the enamel slabs were tested to determine the CaF2 
from each treatment groups. The remaining enamel slabs were mounted in a 
palatal appliance of ten subjects with the enamel surface facing a test plaque 
prepared from S. mutans. The enamel slabs remained in contact with the test 
plaque for 30 minutes, at which time plaque from two of each sample was 
removed to test the amounts of fluoride, calcium, and inorganic phosphorus. 
After this, the appliance was reinserted and subjects rinsed for 1 minute with 
a 20% sucrose rinse. The appliance remained in the mouth for 45 minutes at 
which time the appliance was removed and another plaque sample was 
evaluated for fluoride, calcium and phosphorus. The results indicated that 
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the plaque fluid opposing the fluoride treated slabs had significantly higher 
levels of fluoride than the control and that this was correlated to the initial 
CaF2 concentration in the enamel slab. In addition, the surface micro 
hardness before and after the sucrose challenge, supported the hypothesis 
that this increase in plaque fluid fluoride inhibited demineralization. In this 
experiment the importance of the CaF2, was demonstrated. An acidic 
fluoride solution was used in this experiment, which may work in an 
alternate way to a neutral fluoride compound. 
 To evaluate the remineralization effect of topical fluoride, Castellano 
et al.34 compared how the application of fluoride on a caries-like lesion 
would compare to the application of the fluoride around a caries-like lesion. 
In this study, human molars were sectioned and used in pairs for a control 
vs. experimental sample. Caries-like lesions were created (1x5mm) using an 
artificial caries solution. A 5% NaF varnish (Duraflor) was used to cover 
either the entire surface including the caries-like lesion, or the entire surface 
except the caries-like-lesion. After 30 days, the lesions were photographed 
under polarized light and compared to the baseline lesions. The mean 
percentages of remineralization were 9.5% for the group with fluoride 
surrounding the lesion and 10.8% for the group with the lesion covered with 
varnish. There was not found to be any significant difference between the 
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different application techniques in regards to the remineralization potential. 
These results support remineralization as one of the mechanisms of action of 
fluoride. Furthermore, this study supports the theory that direct application 
of varnish to a carious lesion is not necessary for the desired effect.  
Fluoride Bioavailability 
 It was hypothesized early in the history of fluoride use that the 
prophylactic effect of fluoride was positively correlated with the 
concentration or amount of fluoride utilized. This protective effect was off-
set by the increasing evidence that fluoride, in high concentrations, may pose 
both an esthetic risk (mottling) and toxic risk to humans. In contrast to the 
1900's when the preventative effects of fluoride were discovered, the 
different sources of fluoride available to people today has greatly expanded. 
Fluoride is a vailable today in our dentifrice, water, food sources, and 
professionally applied fluoride rinses, varnishes, and gels. This multi-source 
availability, in addition to the varying possible mechanisms that these 
fluorides work, has led to inquiries of how much, and of which types of 
fluoride containing substances are actually necessary to prevent decay. The 
initial step in answering this question depends on finding reliable ways to 
determine the fluoride release and bioavailability from particular products. 
From there, it may be possible to determine where the available fluoride is 
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incorporated, or if other fluoride containing compounds are formed that may 
be crucial in the cariostatic or carioprotective mechanism of fluoride action.  
In the case of fluoride varnish, it is not enough to simply rely on the 
package label stating the ppm or percentage of fluoride that is contained in 
the product. Interactions between the individual ingredients, the unique 
environment of the oral cavity, and complex biochemical interactions may 
have an effect on the bioavailability of fluoride from the product. Several 
methods for determining the release of fluoride have been utilized. In 
addition to many in vitro studies, in vivo studies have evaluated release and 
subsequent storage of fluoride into saliva, oral mucosa, plaque, enamel, 
blood, urine, etc. It is likely that the fluoride found in whole saliva following 
fluoride varnish application represents the initial bioavailable fluoride from 
the product which can be stored in plaque, soft tissue, incorporated into 
enamel, or bound to other ions or proteins in saliva. Although outside the 
scope of this review, the storage of fluoride in plaque, oral mucosa, or 
through formation of fluoride containing compounds adsorbed onto the 
surfaces of teeth after localized release into saliva is, undoubtedly, an 




Fluoride Release into Saliva 
Many of the early studies evaluating fluoride release into saliva aimed 
to determine the exact amount of fluoride released from very different 
fluoride containing products (gel, foam, dentifrice, varnish). However, using 
this historical literature to make comparisons between similar products 
(varnish vs. varnish); it becomes evident that even similar products types 
and concentrations can release different amounts of fluoride. This 
unexpected finding prompted studies that compared fluoride release to saliva  
A 1983 study by Rytomaa and Meurman35 evaluated the amount of 
fluoride in saliva after using different topical fluoride treatments. At the time 
of this publication, the main cariostatic effect was believed to be the 
reduction of enamel solubility and the direct action on dental plaque. The 
aim of this study was to determine the ability of a 2% sodium fluoride 
solution, an amine fluoride solution (Elmex sol), a sodium fluoride and 
amine fluoride gel (Elmex gel), and a 5% sodium fluoride varnish 
(Duraphat) to increase the ionic fluoride concentration in saliva and remain 
at a significant level. Four subjects were utilized in a cross-over design with 
a two month wash out period. The difference of amount of fluoride ion 
applied varied from 9 mg to 63 mg based on the amount applied and the 
concentration of the product. Stimulated salivary samples were taken at 2, 4, 
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6, and 8 days post treatment, and the samples were analyzed with a fluoride 
specific electrode. The results of this study showed that Duraphat gave the 
highest fluoride peak (10 ppm F- two hours after treatment), and that 
although the Elmex gel and solution both produced a mean of 3 ppm of 
fluoride in saliva 2 hours after treatment, the clearance of the fluoride from 
the gel solution was slower than the solution. All treatments raised salivary 
fluoride levels above the baseline levels, however only Duraphat was able to 
keep this fluoride level above baseline until the next day. Elmex gel 
contained seven times the amount of fluoride than the other solutions but did 
not remain in saliva for an extended period of time which may indicate that 
there was an undesirable amount of fluoride ingested. To investigate this 
hypothesis further, it would be pertinent to evaluate blood levels of fluoride 
following the application of these products. It is possible that although the 
fluoride was not found in saliva the following day from some of these 
products that it was either bound in plaque, oral soft tissue, or enamel.  
Eakle et al.36 compared the fluoride levels found in saliva after the use 
of a 5% NaF varnish (Duraphat), to that of a 0.05% NaF rinse (ACT). Their 
hypothesis was that fluoride levels found in whole saliva represent the 
fluoride that is available to interact with plaque and enamel and therefore is 
a logical place to begin measuring the efficacy of fluoride releasing 
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substances. This study was a two-treatment cross-over design using sixteen 
subjects. Following pilot study results, they determined that they would test 
saliva at the following intervals: 5 and15 minutes, and, 1, 2, 4, 8, 12, 24, 32, 
48, 56, 72, 80, 96, 104 hours. Although they anticipated that the fluoride 
rinse group would return to baseline fluoride saliva levels much sooner than 
104 hours, they wanted to make a direct comparison to the fluoride varnish 
group. For the varnish group an unspecified amount of varnish was applied 
to both the buccal and lingual surfaces of 20 teeth, and for the fluoride rinse 
group subjects rinsed with 10ml of the 0.05% solution for 30 seconds. Saliva 
samples were collected in a stimulated fashion by having subjects chew on a 
piece of Parafilm for 2 m inutes. After the baseline saliva collection, all 
future collections were done by the subjects themselves and labeled with the 
time of collection. The fluoride assays were performed blinded to treatment 
groups and were analyzed with the micro-diffusion method. This study was 
able to demonstrate that the 5% NaF varnish resulted in higher and more 
sustained levels of fluoride in saliva than the 0.05% NaF rinse. Salivary 
fluoride levels remained above baseline for up to 24 hours after the varnish 
application and for 2 hours after the rinse. For both groups the salivary 
fluoride levels peaked within 5 to 15 minutes. There was no carry over effect 
found in this study, and all subjects returned to baseline after a maximum of 
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32 hours. However, for both groups, a period effect was observed in the 
Area Under the Curve (AUC) data. Regardless of the order of treatments, the 
second period AUC's were higher for both the varnish and the rinse. This 
finding may indicate that some portion of fluoride remained in an un-
measurable form, but then was released upon the application of more 
fluoride.  
The amount of fluoride applied to each subject should have been 
included in the methods for direct comparisons. It is feasible that the 
collection of stimulated saliva with the Parafilm prematurely removed 
varnish and increased flow rate, which may have impacted the results. In 
addition the heavy reliance of subject compliance may have introduced 
errors. 
A study conducted by Seppä et al.,37 evaluated not only the fluoride 
concentration in saliva, but in that of the parotid saliva after the application 
of Fluor Protector and Duraphat fluoride varnishes. This study aimed to not 
only evaluate the amount of fluoride release into whole saliva, but to 
evaluate the amount of ingested fluoride that is present when using these 
slow releasing fluoride agents. Parotid salivary fluoride levels can be used as 
rough estimate of fluoride plasma values, and are less invasive to obtain. 
Forty-one participants were randomly divided into the Fluor Protector or 
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Duraphat group, and each had 0.5 ml of the varnish applied to the teeth 
according to manufacturer's instructions. Samples of stimulated parotid 
saliva were obtained at 0.5, 1, 2, 3, 4, 5, 6, 24, 27, and 30 hours after 
application, while whole resting saliva was obtained at 1, 2, 3, 6, 12, 24, 27, 
30 and 48 hours after application. Samples were centrifuged, shaken and 
then fluoride concentration was determined using a fluoride-specific 
electrode.  For whole saliva, the largest amount of fluoride in the saliva was 
seen at hour one, where a mean 12.77 µg/ml (SD 4.34) was seen in the 
Duraphat group, and 3.84 µg/ml (SD 2.12) was seen in the Fluor Protector 
group. By 24 hours the whole saliva fluoride levels were still elevated 
significantly above baseline, but there were no differences between the two 
varnishes. Baseline fluoride values were observed at 24 h, 27 h, and 30 h 
after application. In parotid gland saliva, the peak fluoride levels were 
observed 30 minutes after application for both varnishes. Fluoride values 
were significantly higher in parotid gland saliva after treatment with 
Duraphat during the first 5 h ours. Baseline fluoride values were observed 
between 24 hours and 30 hours for parotid saliva in b oth varnish groups. 
This study effectively showed that differences can exist between two 
fluoride varnishes, however, it is hard to make a direct comparison because 
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these varnishes contain very different amounts of fluoride in their 
formulations (0.1% Fluor Protector, 2.26% Duraphat).  
In 1999, Twetman et al.38 performed a crossover study with eight 
subjects that evaluated the fluoride concentration in unstimulated whole 
saliva and paraffin-stimulated whole saliva after the application of Bifluorid 
12 (6% F-, 6% Ca 2+), Duraphat (2.26 % F-), and Fluor Protector (0.1 % F-). 
They applied the varnish to the buccal and lingual surfaces of all teeth and 
the occlusal surfaces of the molars and premolars. For Bifluorid and Fluor 
Protector they used 0.5 ml, and for Duraphat 0.75 ml. Whole unstimulated 
saliva was obtained by the passive drooling technique, and stimulated saliva 
was collected by means of chewing paraffin wax. Samples were centrifuged 
and the concentration of fluoride was determined using a fluoride sensitive 
electrode at baseline and 1, 6, 12, and 24 hours after fluoride application. A 
6 week washout period was observed between test periods. Within the 
limitations of their study, they were able to determine that salivary fluoride 
levels did correlate with the different amounts of fluoride in the varnishes, 
however the correlation was not linear which indicated that the amount of 
fluoride availability could not be adequately predicted by simply knowing 
the amount of fluoride applied. Additionally, their results showed a trend of 
decreased amount of fluoride found in the unstimulated saliva compared to 
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the stimulated samples for both Duraphat and Fluor Protector. They 
hypothesized that chewing paraffin-wax dislodges varnish leading to higher 
levels of salivary fluoride levels in stimulated saliva. Because this study 
used varnishes with varying concentrations of fluoride, and they applied a 
different amount of Duraphat, a direct comparison of fluoride release 
differences among the three varnishes cannot be made.  
Ritwik et al.9 decided that although several studies were available 
regarding the release of fluoride over an extended time period, there was a 
lack of literature describing the immediate release of the fluoride from 
varnishes which they hypothesized to be the most important aspect from a 
clinical standpoint. In 2012 they designed an in vitro study to evaluate the 
fluoride release from Enamel Pro (Premier), PreviDent (Colgate), Vanish 
(Omni), and Vanish XT (Omni) that happened over a 48 hour time period. 
The first three products are varnishes while Omni Vanish XT is a light cured 
resin-modified glass ionomer. The products, described as having the exact 
same fluoride concentrations (5% NaF), were applied to a 5X5 enamel 
surface window of extracted teeth. The amount of varnish applied was 
accounted for by weighing the sample before and after varnish placement. 
Vanish XT wa s light cured for 20 s econds after placement per 
manufacturer's instructions. The teeth were immersed in artificial saliva after 
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treatment, and at intervals of 1, 2, 4, 8, 12, 24, and 48 hours, they were 
transferred to a new container of fresh artificial saliva. Each vial of artificial 
saliva was tested using a fluoride specific electrode. From their results, they 
were able to conclude that despite the similar fluoride concentrations found 
in each product, there were significant differences regarding their pattern, 
and amount of fluoride release. Enamel Pro showed the greatest amount of 
release within the first eight hours compared to the other varnishes, while 
Vanish XT showed low release in the first 4 hours but maintained the 
highest fluoride release after the 4 hour time period. They hypothesized that 
the carrier component of the varnish was responsible for the difference in 
this fluoride release.  
This study was well designed and controlled, however the researchers 
did not state how they determined the concentration of fluoride in the Vanish 
XT. The product information guide does not state this is a 5% NaF 
concentration which has the potential to make direct comparisons with this 
product invalid.  
In a recent study, Jablonowski et al.10 evaluated in vitro fluoride 
release of four different fluoride containing products including three 
varnishes; Enamel Pro, Vanish, and Duraphat, as well as the light-cured 
resin-modified glass ionomer material, Vanish XT. Using twenty-five third 
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molars sectioned into four blocks, samples were divided into five different 
groups, one group for each varnish, plus a control group. Each varnish was 
applied to only the enamel portion of the tooth sections, a total of 3 mg was 
applied to each sample, except the control group. Samples were dried for 24 
hours and then immersed in 30 ml of artificial saliva. Using a fluoride 
combination ion-selective electrode, the artificial saliva was tested to 
determine the concentration of fluoride after 30 minutes, daily, and then 
weekly until the concentration was below the electrode detection level. By 
comparing the fluoride concentrations of the different varnish-saliva 
solutions between specific time periods, a significant difference in fluoride 
release was found between the varnishes evaluated. It was determined that, 
for all the varnishes, the greatest rate of fluoride release was from baseline 
up to three weeks. The differences in rate of fluoride release at each time 
interval between the products was significant (Enamel Pro > Vanish > 
Duraphat > Vanish XT). The rate of overall fluoride release was 
significantly more for Enamel Pro than Duraphat; however Vanish and 
Vanish XT were not significantly different. Additionally, Enamel Pro 
displayed a greater cumulative amount of fluoride release than the other 
products. This study, although in vitro, was well designed demonstrated that 
there may be complex interactions between fluoride and the carrier 
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formulations that affect the overall fluoride release. Unfortunately they did 
not state the fluoride concentration in Vanish XT therefore it is hard to 
determine if the data from this product can be compared directly to the other 
products.  
Experimental Design 
 Currently, the literature regarding fluoride release and bioavailability 
contains large variations in experimental design, limiting the possibility of 
comparing their results. Some of these experimental design components that 
will be discussed below include the type of saliva, collection and handling 
method, and analytical techniques used to determine the fluoride 
concentration in sa liva. These methods, for various reasons, have the 
greatest potential to affect variability in the study results. 
Saliva Type 
 In his publication Clinical Aspects of Salivary Biology for the Dental 
Clinician, 39 Walsh describes up to eight major functions of human saliva 
important to oral health, one of which is to serve as a reservoir for ions 
involved in remineralization. He states that salivary flow, which can range 
from 0.03 ml/min up to ≥ 1 ml/min, is affected by stimulation and the time 
of day it i s measured. The components of saliva are a combination of the 
minor and major salivary glands, and they may be considered a 
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representative of the blood serum. Whole saliva is 99% water, and is made 
up of mucinous saliva from the submandibular gland, serous saliva from the 
parotid gland, with minor contributions from both the sublingual and other 
minor salivary glands. 
 Saliva can be classified by either glandular or whole, and by either 
resting or stimulated. In many cases, analytes of interest to a researcher are 
produced in different concentrations by the different salivary glands. In this 
case, there may be a particular reason to sample the saliva coming from only 
one gland. For example, Seppä et al.37 evaluated both whole saliva and 
parotid gland saliva fluoride levels in order to determine what percentage of 
the fluoride ion calculated came from release directly into saliva from the 
product, compared to that amount that was coming from the serum or blood 
represented by in the parotid gland saliva. Studies involving the 
quantification of systemic or ingested fluoride will commonly evaluate 
parotid saliva as a less invasive representation of blood fluoride levels. 
Whole saliva, which represents a mixture of all the saliva available in the 
oral cavity, is commonly used when calculating the fluoride release directly 
from a material into the oral cavity; because it represents the fluoride that 
would be available to act topically, which is fluoride's principal mechanism 
action. A shortcoming of this method is that in addition to measuring 
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fluoride released directly into saliva from the product, you may inadvertently 
be measuring fluoride currently in the blood stream that is released from the 
salivary glands. If the data collected happens within the first hour, this 
amount is thought to be negligible because serum fluoride levels peak 20-60 
minutes after ingestion and then is excreted from the kidneys within 3-6 
hours.40  
 In one study, conducted by Fukushima et al.40 the differences between 
parotid duct saliva and whole saliva were examined. The aim of this study 
was to determine which saliva type, ductal or whole, would be a better 
indicator of exposure levels to fluoride. Using 300 subjects from five 
communities with different water fluoridation levels (0.0-1.68 mg/L), 
unstimulated whole saliva and parotid duct saliva were collected. The 
amount of fluoride found in each sample was then compared to the known 
amount of fluoride found in the community’s drinking water. Age, gender, 
and geographical locations of the subjects were also analyzed to determine if 
any influence of these factors on salivary fluoride levels could be seen. 
Salivary fluoride levels were determined using an inverted ion-specific 
electrode. The results showed that the water fluoride concentration was the 
main factor influencing fluoride levels in parotid duct saliva, but not whole 
saliva. The authors concluded that parotid duct saliva is a better indicator of 
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systemic fluoride and can be considered a good biomarker for exposure to 
fluoride in above-optimum levels from water. This research supports the use 
of whole saliva rather than parotid saliva to detect fluoride bioavailability 
from direct release of high fluoride containing products. Ductal saliva 
analysis would reflect systemic fluoride levels which are not believed to be 
the main mechanism of action fluoride in caries prevention.  
 In support of Fukushima's findings, Olivby et al.42 demonstrated that 
the concentration of excreted fluoride ion from the 
submandibular/sublingual, and parotid glands closely reflects the serum 
fluoride levels and can be a good predictor of systemic fluoride levels. This 
study also verified that glandular salivary fluoride concentration is 
independent of the glandular flow rate. This characteristic differs from 
fluoride analysis done from whole saliva.  
  The influence of flow rate on the bioavailability of fluoride in whole 
saliva was examined by Naumova et al.43 In this study the whole saliva of 
ten different test subjects was analyzed to determine the concentration of the 
fluoride ion after delivery of either a 1450 µg/g NaF tablet (DENTTABS) or 
use of 1400 µg/g amine fluoride (EMLEX) dentifrice. Subjects were 
identified as either normal or fast salivary secretors based a five minute 
collection period. Subjects producing 0.3g-0.6 g/min were classified as 
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normal secretors, and those producing > 0.6 g/min were described as fast 
secretors. Subject baseline saliva was taken in a ddition to their saliva 
immediately after the use of the fluoride containing products. Using a cross-
over study design all subjects repeated the two study arms five different 
times with a three day washout period in between. The result showed that 
salivary flow rate had a significant effect on the total amount of fluoride ion 
present in the saliva sample. Individuals with higher salivary flow rates 
tended to have saliva with a lower amount of fluoride.  
 Studies conducted by Zero et al.44 and Brunn et al.45 demonstrated the 
same negative correlation between salivary flow rate and fluoride ion 
concentration in whole saliva following the use of high fluoride products. 
Clinically, this may have implications in getting the desired amount of 
fluoride to stay around the oral cavity of individuals that have high salivary 
secretion rates. Experimentally, this c omplicates the ability to adequately 
determine the amount of fluoride release into saliva from different fluoride 
containing products due to possible flow rate differences among subjects. 
For this reason, cross-over study designs using this methodology of fluoride 
concentration analyses are indicated.  
 Finally, determining the preference for stimulated versus unstimulated 
saliva for sampling, there are several considerations. According to Walsh,39 
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the majority (60%) of resting saliva is derived from the submandibular gland 
which produces mostly mucinous saliva high in mucin proteins and calcium. 
Parotid saliva, in contrast, comprises only 20% of resting saliva, is high in 
bicarbonate and amylase and termed serous saliva. Submandibular salivary 
secretion rate increases by stimulation of chemoreceptors, while parotid 
gland secretion is mainly influenced by mechanoreceptor stimulation. Walsh 
contends that the protein content found in s ubmandibular saliva has the 
potential to interfere or bind to free ions in saliva. For fluoride varnish, 
which is intended to adhere to tooth surfaces for prolonged fluoride release, 
the use of stimulation by chewing has the potential to prematurely dislodge 
the varnish, and increase salivary flow rates thereby leading to altered 
results. Stimulated saliva collection is advantageous in some cases because 
of the ability to rapidly collect larger amounts of saliva.  
Collection and Handling  
 The method of saliva collection can play a large part in the acquisition 
and subsequent analysis of an analyte of interest. Salimetrics,46 a corporation 
based in Pennsylvania, offers one of the most extensive, research supported 
literature for determining methods to obtain clean salivary samples for 
analysis of several different analytes. In their handbook Saliva Collection 
and Handling Advice, they outline proper ways to collect saliva, avoid 
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contaminants, and store samples for future use. For some analytes, variations 
can be seen based on diurnal cycle, stress levels, or salivary flow rates. 
Additionally, contaminants such as alcohol, food, caffeine, nicotine, 
medications or blood, must be considered. They recommend avoidance of 
food 60 minutes prior to sample collection and documentation of the 
subject’s use of alcohol, caffeine, nicotine, or medications. They indicate 
that the passive drool technique is a cost effective way to obtain whole saliva 
that can be used for almost all analytes. In this method, the subject tilts his 
head forward and allows for unstimulated saliva to pool before letting the 
saliva flow into a collection vial. Saliva samples are then stored at -20ºC to  
-80ºC until analyzed.  
 Recently the handling techniques used in salivary fluoride analysis 
studies have been an area of interest. Historically, many studies centrifuged 
the salivary samples and analyzed the supernatant alone as a way to 
eliminate interference from fluorides found in salivary sediment which Gron 
et al.47 hypothesized to reflect levels more similar to that found in plaque. 
Additionally, analysis of the supernatant has the advantage of creating clean 
samples with minimal interference from mucin protein globules which tend 
to become suspended in saliva creating a non-homogeneous solution.  
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 Naumova et al.48 conducted a study to determine if differences existed 
between the analyses of fluoride in the different phases of saliva. They 
hypothesized that the sediment, which contains cellular, proteins, and food 
debris, may be an important source of fluoride bioavailability, despite the 
fact that several studies examine the supernatant alone. Their specific aim 
was to assess the fluoride content found in t he sediment and supernatant 
phases of saliva after centrifugation.  In this cross-over study design, seven 
subjects either brushed with an amine fluoride dentifrice (EMLEX) 
containing 1400 ppm F-, or chewed a sodium fluoride tablet (DENTABS) 
containing 1450 ppm F- at least 10 times and then brush with the particulate. 
All subjects completed both experimental arms twice and had a minimum 
seven day washout period between. Saliva samples were obtained at 
baseline, 3, 30, 120, and 360 minutes after brushing. 1.5 ml of saliva was 
centrifuged for 10 min at 3024 x g, and 1 ml of supernatant was removed 
from the sample, leaving 0.5ml of sediment. For analysis, equal parts of 
TISAB II were added to the samples. The samples of sediment and 
supernatant were analyzed with a fluoride-sensitive electrode. The results 
indicated three main things. First of all, there were significant differences 
between the amine and fluoride group in the total amount of fluoride found 
in both phases of saliva. Secondly, the dispersion of fluoride found in the 
 43 
different phases was significantly different, with the amine fluoride group 
having more fluoride recovery from the sediment than the supernatant. 
Lastly, the overall amount of fluoride found in the different phases was 
significant for both groups, and the ratio of the mean sediment to supernatant 
fluoride ranged from 0.07-31.6 across the time periods. In general, the 
amount of fluoride found in the sediment was greater than that found in the 
supernatant for all time periods, for both fluoride groups. This study 
indicates that centrifugation prior to fluoride analysis may be missing an 
important portion of the total fluoride available from products.  
Analytical Methods 
 Several methods exist to analyze trace levels of fluorides in materials. 
Well established methods include the potentiometric, gas chromatography, 
and the rapid diffusion techniques.  
 Evaluation of the literature suggests that for biological samples, the 
most common method is the potentiometric technique using an ion selective 
electrode (ISE). In this method, a lanthanum fluoride plate doped with 
europium++ is used at the base of a probe to quantify fluoride activity in a 
solution. This method is commonly used because of its rapid analytical 
capabilities, relative accuracy and ease of use. Frant and Ross49 first 
described the use of this probe for evaluation of fluoride ion activity in 1966. 
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They described that the lanthium fluoride plate is impermeable to other ions 
and therefore the resulting relationship of fluoride ion activity to 
millivoltage readings follows Nernstian behavior from 1- 105 M. Aside from 
the hydroxide ion, which can be adjusted for by changing the pH of the 
solution, other ions do not appreciably interfere with the electrode. The 
method of pH adjustment used today is by use of a Total Ionic Strength 
Adjustment Buffer (TISAB) as described by Frant and Ross50 two years later 
in 1968.  
 Frant and Ross were experimentally looking for a solution that would 
have three main purposes for its use in fluoride ion analysis. First they 
wanted a solution to buffer the solution to a pH less than 8.5 to a void 
hydroxide ion interference.  Second they needed to increase the ionic 
strength of the water by adding more ions than were normally present in the 
solution. Finally they needed citrate present in order to complex Fe3+ and 
Al3+ to displace any bound fluoride to these ions. Their TISAB reagent 
consisted of 57 ml Acetic Acid, 58 g of NaCl, 0.30 g sodium citrate, and 500 
ml H2O. Experimentally, Frant and Ross were able to determine that the 
addition of this TISAB in a  1:1 ratio with their samples allowed for the 
lower direct determination of concentration in water to + .005 ppm. Without 
the use of TISAB, 25% of their lower limit samples fell below the best fit 
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standard curve line. At the time they hypothesized that this solution would 
allow direct readings for low fluoride concentrations in a variety of aqueous 
solutions. The TISAB reagent is currently still used for both the direct and 
indirect analysis of low fluoride ion detection in solution, including saliva.  
  According to t he Department of Health and Human Services1, the 
most accurate technique in fluoride analysis is the microdiffusion technique. 
In 1968 Taves50 described this method using hexamethydisiloxane saturated 
acid as a way to speed up the process of diffusion. Although very accurate, 
this method is technique sensitive and requires more time than the direct 
method. According to Taves, greater than 97% recovery in one hour at room 
temperature is possible. Following diffusion of the fluoride ion into a 
sodium hydroxide trap, further analysis is required to determine the amount 
of fluoride trapped. This can be done with one of the other techniques of 
fluoride analysis such as the direct technique using a fluoride ion specific 
probe.  
 In an attempt to standardize the most common methods of fluoride ion 
analysis, Martinez-Mier et al.52 conducted an experiment which evaluated a 
total of nine different labs analytical techniques and results from a set of 
standardized fluoride samples. These labs were all using either the direct 
technique, or the microdiffusion technique. Broken down into three phases, 
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labs were first instructed to describe their current technique and provide 
results for a set of biological and non-biological samples. After this, 
inconsistencies between the different techniques were identified and labs 
reanalyzed the samples using the various techniques documenting the 
results. Finally these results from the various techniques were distributed to 
the nine labs and a plan was made to standardize the techniques providing 
the most accurate results. After the technique was agreed upon, each lab re-
analyzed the biological and non-biological samples and the intraclass 
correlation coefficient (ICC) was found to be 0.93 for the direct analysis and 
0.90 for the microdiffusion technique. The specific recommendations for 
each technique were further outlined in this paper, which also concluded that 
samples below 0.0105 µmol F/g could be analyzed either with a blank 
correction or two-term polynomial regression equation. The authors 
concluded that ion-selective potentiometric methods were the technique of 
choice due to the ubiquitous use, ease of accessibility, and acceptable lower 
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Objective: To compare the release of fluoride into unstimulated whole 
saliva in vivo after the application of three different 5% NaF varnishes: 
Enamel Pro, Vanish, and Duraphat.  
Experimental Methods: Following IRB approval, 15 subjects were 
recruited and consented based upon the inclusion/exclusion criteria of the 
study. A four-treatment randomized cross over study design with a 2-week 
washout period between treatments was used. Treatment consisted of the 
application of 0.4 ml of either a 5% NaF varnish, or a placebo (no fluoride) 
varnish applied to the buccal surfaces of all the teeth. After a minimum of 2 
weeks washout period, the next randomly assigned treatment was given. All 
subjects received the 4 different treatments and during each treatment 
unstimulated whole saliva was obtained at baseline and 1, 4, 6, 26, and 50 
hours. Following storage, saliva samples were centrifuged and the 
supernatant salivary fluoride was measured using a fluoride ion specific 
electrode to compare unknown values with a standard curve. Mixed linear 
effects models were used to evaluate the effects of varnish and time on 
salivary fluoride concentration. Significance was determined at 5% level for 
all tests.  
Results: For time periods 1, 4, 6, and 26 hours, treatment with Duraphat and 
Vanish resulted in significantly higher mean concentrations of salivary 
fluoride than Enamel Pro, but were not different from each other. 50 hours 
after treatment, mean salivary fluoride levels for Duraphat were greater than 
all other treatments. For all the fluoride containing varnishes, the maximum 
amount of fluoride was measured at the 1 hour time point [D (18.94±9.95), 
V(19.78±14.57), EP (6.19±4)] and the fluoride concentration decreased at 
each time point thereafter. When treated with Enamel Pro and Vanish, mean 
baseline salivary fluoride concentrations were reached by 26 hours. Mean 
salivary fluoride concentrations with Duraphat treatment was still above 
baseline at the 26 hour collection point. 
Conclusions: Salivary fluoride concentrations after treatment with Duraphat 
and Vanish are similar over 26 hours. Treatment with Enamel Pro resulted in 
significantly less fluoride in saliva over 26 hours.  Despite the similar 
fluoride concentrations, the fluoride release into saliva from these varnishes 






Fluoride varnish production and use has had a dramatic increase in the 
last decade following approval by the FDA in 1994 as a cavity liner and root 
desensitizer.1 Despite its "off-label" use in caries prevention, research has 
demonstrated varnishes to be a safe, effective, and efficient way to deliver 
fluoride to patients at risk for dental caries.2,3 Accordingly, fluoride 
varnishes are widely recommended for patients at high risk for dental caries 
(ADA, CDC, AAPD). Although the FDA did not approve fluoride varnishes 
until 1994, the first fluoride varnish was developed in the 1960's as a 
possible mechanism to enhance the treatment duration and uptake of 
fluoride.4 Most of the clinical research on fluoride varnishes has been 
conducted using Duraphat (5% NaF), which was the first commercially 
available product.  
Within the last few years, numerous varnishes with similar sodium 
fluoride concentrations (5%), but with multiple variations in carrier 
composition, have emerged and have taken a significant portion of the 
market share. As the number of fluoride varnishes available has increased, 
each company has created unique changes to the formula in order to improve 
properties like handling, appearance (i.e., white), flavor, or in some cases, 
 55 
potentially active ingredients (e.g., tricalcium phosphate, amorphous calcium 
phosphate, calcium sodium phosphosilicate, xylitol, etc.),5-8 leading to a 
claim of additional preventive benefits. Most of these new varnishes have 
not been studied in vivo for their caries reduction, efficacy, or safety. 
Despite the similar 5% NaF concentration used in most of these 
varnishes, in vitro data have suggested that some of these secondary 
ingredients may affect the fluoride ion release of the product.9,10,11 Fluoride 
release, and subsequent formation of calcium fluoride  is thought to be an 
essential part of the mechanism of action of fluoride varnishes to prevent 
and remineralize carious lesions. Differences in fluoride release patterns can 
potentially enhance or diminish the efficacy and safety of a varnish. 
Therefore, understanding the differences in fluoride release pattern of 
varnishes with different formulations in vivo will help us understand which 
formula modifications have the potential to enhance or diminish the 
anticariogenicity and safety of the varnish. Several studies have compared 
fluoride varnishes to other delivery systems such as gels, foams, and 
pastes,12,13 however, a void remains in the literature regarding the 
comparison of efficacy and safety between the many different new fluoride 
varnish systems containing 5% NaF widely available today.  
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The aim of this study was to evaluate the fluoride release from three 
different 5% NaF varnishes. By comparing the fluoride release as measured 
by concentration of fluoride in whole unstimulated saliva of participants, we 
wanted to gain some insight to the complex interaction of these trade secrets 
in vivo and the potential effect they may have on fluoride varnish efficacy. 
Hypotheses 
Ho1 - There will be no significant difference in the amount of fluoride 
release into saliva among the 3 different varnishes.  
Ha1 – There will be a significant difference in the amount of fluoride release 
into saliva release among the 3 different varnishes. 
Ho2 – There will be no significant difference in the timing of fluoride 
release in to saliva among the 3 different varnishes. 
Ha1 – There will be a significant difference in the timing of fluoride release 
into saliva among the 3 different varnishes. 
Methods and Materials 
Subject Recruitment 
 Prior to subject recruitment, approval was obtained from the 
Institutional Review Board, University of Michigan Medical School 
(HUM00062943). The clinical trial was registered at ClinicalTrials.gov. 
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(NCT01629290). Subjects were subsequently recruited at the University of 
Michigan School of Dentistry primarily by word of mouth. Individuals who 
had signed the informed consent qualified for participation in the study 
unless they met any of the following criteria for exclusion: having less than 
20 teeth, having significant untreated medical conditions, being pregnant or 
lactating, requiring pre-medication prior to dental treatment, having known 
allergies to fluoride varnishes, and having no history or current carious 
lesions. Additionally, subjects that stated they would not be available for 
each cycle of the study did not qualify for participation. Subjects meeting the 
inclusion criteria were further screened for adequate salivary production. 
Those subjects able to produce 2 ml of unstimulated saliva in a two minute 
time period were included in the study and given a subject number based on 
their order of consent. 
A total of seventeen subjects were included in the study. Fifteen were 
given a number 1-15 and the remaining two served as back-ups. There were 
no drop outs during the study period, and the original fifteen subjects 
completed the 4 experimental arms.  
Varnish Selection 
The different fluoride varnishes were chosen for this study based on 
their identical concentration of sodium fluoride (5%), commercial 
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availability, presumed popularity, and clear use of different carrier materials 
and clinical appearance (Table 1). Although all subjects lived in fluoridated 
communities and reported using fluoridated toothpaste, a placebo varnish, 
made by the Premier Dental Company, with no sodium fluoride was utilized 
as a means for comparison of background salivary fluoride concentrations. 
The placebo varnish was tested and the absence of fluoride in the 
formulation was verified. Like the other varnishes, the placebo varnish had 
unknown amounts of other ingredients but was presumed to be similar to the 
components found in the experimental varnish Enamel Pro. 
Table 1. Experimental Varnishes 
Varnish Company Active Ingredient Marketed Additives 
Vanish 3M ESPE 
(St.Paul, MN) 5% NaF 
Tri-Calcium Phosphate 
(TCP) 
Enamel Pro Premier 





(New York, NY) 5% NaF None 
Placebo Premier 
(Plymouth Meeting, PA) N/A N/A 
 
Varnish Application      
 
Using the unique subject number and the different varnishes to be 
applied, a randomized table was created using a random number generator 
service (www.random.org) to determine the order of application for each 
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subject (Table 2). The subjects were blinded to the order of varnish 
application and to the name of the varnish, however because of the 
uniqueness of each varnish (flavor, color, adherence etc.) the subjects had 
the potential to d iscriminate between the varnishes. Varnish application, 
saliva collection, and saliva analysis was carried out by the same person who 
was not blinded to varnish application, but was blinded to sample analysis.  
Table 2.  Randomized Treatment Sequence 
 
  
 Each active varnish (3) and the placebo varnish (1) was applied one 
time to each subject and saliva was collected over a total of 50 hours after 
application. Between different varnish applications a minimum of two weeks 
was allowed for wash-out from prior varnish applications, this protocol 
Subject Treatment 1 Treatment 2 Treatment 3 Treatment 4 
1 Placebo Enamel Pro Duraphat Vanish 
2 Enamel Pro Duraphat Placebo Vanish 
3 Duraphat Enamel Pro Vanish Placebo 
4 Duraphat Enamel Pro Placebo Vanish 
5 Enamel Pro Vanish Placebo Duraphat 
6 Vanish Enamel Pro Duraphat Placebo 
7 Enamel Pro Duraphat Vanish Placebo 
8 Duraphat Enamel Pro Vanish Placebo 
9 Duraphat Vanish Placebo Enamel Pro 
10 Vanish Enamel Pro Placebo Duraphat 
11 Duraphat Placebo Enamel Pro Vanish 
12 Enamel Pro Placebo Vanish Duraphat 
13 Vanish Duraphat Placebo Enamel Pro 
14 Enamel Pro Placebo Duraphat Vanish 
15 Enamel Pro Placebo Vanish Duraphat 
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applied to the placebo as well. In total, all subjects completed four rounds of 
varnish application and saliva collection. Varnish containers and brushes 
were weighed prior to the application and afterward for determination of the 
actual amount of varnish applied.  
 On the morning of varnish application, subjects were instructed to 
refrain from brushing. Subjects were given a new toothbrush when they 
presented to the clinic between 8 am and 10 am and were instructed to brush 
with a non-fluoridated toothpaste (Fruit Splash Training Toothpaste, Orajel 
Toddler, Chrurch & Dwight Inc. Princeton, NJ) for a total of 1 minute. 
Health history was reviewed and updated as necessary and each subject was 
given a soft tissue exam noting any pre-existing lesions or deviations from 
normal. Following the exam, subjects provided 2 ml of unstimulated, whole 
saliva using the drooling technique to serve as a baseline comparison 
(Heintze et al., 1983). In this technique subjects were seated in a quiet 
operatory and told to allow saliva to pool at the base of their mouth without 
sucking or stimulating flow. Saliva was then allowed to passively flow from 
their mouth into a medicine cup. This technique was used for all saliva 
collection times.  
Using a soft tissue retractor (Optragate®, Ivoclar Vivadent, Amherst, 
NY) for isolation, teeth were lightly air dried with an air water syringe tip, 
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and 0.4 ml (actual amount determined later) of varnish was applied to the 
buccal surface of each tooth. In cases where varnish was leftover in the 
container after initial layer, another layer was applied over the first layer 
until no more was available for application. Following application, the 
Optragate® was removed, and the remaining varnish container, plus the 
application brush was saved for determining the actual amount applied.  
 Subjects were given instructions to avoid hard foods, alcohol, or warm 
liquids for 24 hours. These instructions were a combination of post 
application instructions provided by the different varnish companies. 
Additionally, aside from water, subjects were instructed to refrain from 
eating or drinking 1 hour prior to a ny of the saliva collection times, and 
subjects were given a list of foods potentially high in fluoride to avoid 
throughout the three day study period (i.e., sardines, green tea). All oral 
hygiene procedures were forbidden during the first 26 hours. After the 26 
hour collection time, subjects were allowed to brush and floss with the non-
fluoridated products provided. Each subject was provided with a new 
fluoride free toothbrush at the 26 hour collection period to avoid the use of 
their personal fluoride contaminated toothbrushes.  
Sample Collection 
At time periods of 1h, 4h, 6h, 26h, and 50h after varnish application, 
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subjects returned for saliva collection. At each collection period, a minimum 
of 2 m l of unstimulated, whole saliva was obtained by the drooling 
technique over a 5 minute time period. In total, subjects provided six 2 ml 
samples at each of the following time periods; baseline, 1 h, 4h, 6h, 26h, and 
50h. Following a two week or greater wash out period, subjects returned for 
the application of a different varnish. All treatments were randomized and 
each subject participated in four study arms (three experimental, and one 
placebo) in which each subject ultimately received all treatments. Saliva was 
collected in a medicine cup and transferred to an eppendorph tube where it 
was stored within an hour of collection to a -18ºC freezer. At the end of the 
day all samples were transferred to a -80ºC freezer for future analysis. All 
known deviations from the time periods or protocol were recorded. 
Sample Preparation 
 Saliva samples were removed from freezer and thawed at room 
temperature (24 ºC) for one hour. After thawing, samples were loaded into a 
centrifuge machine (Spectrafuge 16M, Labnet, Edison NJ) and centrifuged 
at 10,000 x g for 10 minutes. After removal, 0.7 ml of the supernatant was 
removed and added to a  scintillation vial containing 0.7 ml of TSAB II 
(Orion TISAB II with CDTA, Thermo Scientific, Waltham, MA) for a total 
volume of 1.4 ml. 
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Creating a Fluoride Standard Curve 
 Prior to sample analysis, serial dilutions of a 0.1M fluoride standard 
(Orion Ionplus® Fluoride Standard, Thermo Scientific, Waltham, PA) were 
made to produce nine samples of known fluoride concentrations (0.02-10.0 
ppm) The mV readings were obtained using the fluoride specific ion probe 
(Orion 4 Star pH ISE Benchtop, Thermo Scientific, Waltham, MA). The mV 
was then used to create a fluoride standard curve where determination of the 
fluoride concentration of the unknown samples could be compared. For the 
unknown samples that fell below 0.02 ppm based on the linear standard 
curve, a second two term polynomial regression curve was constructed to 
closer approximate the fluoride concentrations. This curve was remade each 
day prior to sample analysis, and was re-checked after every 2 hours of 
sample analysis to check for electrode sensitivity changes (drift). According 
to manufacture directions, drift of less than 3% is acceptable. There was no 
drift greater than 2% during the analysis of the samples.  
Sample Analysis 
To the 1.4 ml samples, a magnetic stir bar was added and they were 
placed on a magnetic stirrer (2 Mag Mix 15 Eco, Scragenhofstr, Muchen 
Germany) for a minimum of fifteen minutes before analyzing. The fluoride 
specific electrode (Orion 4 S tar pH ISE Benchtop, Thermo Scientific, 
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Waltham, MA) was submerged into the mix while the mix was being 
continuously stirred and the mV reading was recorded. This mV reading was 
compared to the fluoride standard curve made that day for the determination 
of ppm F- in the sample. All samples were analyzed with this technique. All 
analyses were carried out at room temperature of 24 ºC. 
Statistical Analysis 
 To determine if there was a significant difference in the amount of 
varnish applied to the subjects , a Kruskal-Wallis One Way Analysis of 
Variance on Ranks followed by a Pairwise Multiple Caparison Procedure 
(Tukey Test) was performed using a 5% significance level (p<0.05). 
 To evaluate the effects of varnish and time on salivary fluoride 
concentration, linear mixed effects models were used. The models included 
the order of varnish application as a covariate, random effects for subject, 
and an unstructured variance/covariance matrix for the repeated 
measurements within each study period. The analyses were repeated using 
amount of varnish applied as a covariate. A natural logarithm transformation 
(not displayed) of the saliva fluoride measurements was used in the analyses. 
No adjustments were made for multiple comparisons, and a 5% significance 




 The results include data from 15 subjects, each having a total of three 
5% NaF varnishes and a placebo applied during the course of the study. 
Table 3 displays the mean and standard deviation in g of product applied for 
each treatment. The amount of Vanish applied was found to be significantly 
less than that of the other varnishes. There was no significant difference in 
the amount of Duraphat, Enamel Pro, or Placebo applied.  
Means and standard deviations of the concentration of fluoride in 
saliva (ppm) over time are shown in Table 4. Comparisons among the 
varnishes at specific time periods are displayed in rows. For 1 hour through 
26 hours after treatment, subjects treated with Duraphat and Vanish had  
significantly higher salivary fluoride levels than those treated with Enamel 
Pro and Placebo. Treatment with Enamel Pro gave significantly higher levels 
of fluoride in saliva than the Placebo, but subject fluoride saliva levels after 
treatment with Duraphat and Vanish were not different from each other. 
After 50 hours, subjects treated with Duraphat had significantly higher 
amounts of fluoride in saliva than those treated with Vanish and Placebo, 
while none of the other treatments were different from each other. Although 
there was found to be a statistically significant lesser amount of Vanish 
applied compared to the other varnishes, this did not change any of the 
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results when taken into account in the analyses.   
Table 3. Actual amount of product applied (± SD; in g) 
  
Table 4. Mean concentration (± SD; in ppm) of fluoride in saliva over time 
 
Time point comparisons for each varnish are also shown in Table 4 
displayed by column. For Duraphat, the fluoride concentration in saliva was 
significantly higher than baseline for 1 hour through 26 hours after treatment 
Varnish Mean (SD) 
Duraphat 0.30 (0.07)a 
Vanish 0.25 (0.04)b 
EnamelPro 0.29 (0.04)a 
Placebo 0.26 (0.05)a 
Groups with same letters superscripts were not significantly different (p<0.05) 























































Data in rows with the same letter superscript are not significantly different (p< 0.05) 
Data in columns with the same numeric superscripts are significantly different (p<0.05) 
 67 
but was lower than baseline 50 hours after treatment, and decreased 
significantly between each time point after treatment. For Vanish, the 
fluoride concentration in saliva was significantly higher than baseline for 1 
hour through 6 hours after treatment, was not different from baseline 26 
hours after treatment, was lower than baseline 50 hours after treatment, and 
decreased significantly between each time point after treatment. For Enamel 
Pro, the fluoride concentration in saliva was significantly higher than 
baseline for 1 hour through 6 hours after treatment, was lower than baseline 
26 and 50 hours after treatment, and decreased significantly between each 
time point after treatment except for no significant change between 26 and 
50 hours. For Placebo, the concentration of fluoride in saliva was 
significantly higher at baseline than at any time point after treatment, and 
there were no significant differences among any time points after treatment.  
The differences in the concentration of fluoride in saliva are displayed 
graphically in figures 1 and 2. Figure 1 displays the mean and standard 
deviation of the entire sample for each varnish (n=15). Figure 2 displays the 
individual variation in salivary fluoride concentration of the subjects for 




Figure 1. Mean concentration of fluoride in saliva varnish over time 
 




 Saliva is the initial medium into which fluoride that is released from 
dental products is able to achieve the desired effect intra-orally. This study 
evaluated saliva in order to make comparisons between different brands of 
topical fluoride varnishes with similar fluoride concentrations in order to 
observe potential differences in their in vivo fluoride release. The primary 
null hypothesis was rejected based on the statistical analysis indicating a 
significant difference between the fluoride concentrations found in saliva 
after treatment with the different 5% NaF varnishes. The primary alternate 
hypothesis failed to be rejected because subjects had significantly less 
fluoride in saliva when treated with Enamel Pro compared to the other 
products. These findings, although different than the findings in several in 
vitro studies 9,10,11 in which Enamel Pro released more fluoride, still support 
the notion that factors other than the concentration of fluoride may play a 
role in the overall fluoride release of a varnish.   
Unlike many of the previous studies evaluating fluoride release into 
saliva,12,14,15 a conscious effort was made to apply equal amounts of the 
fluoride product to each subject in order to determine if properties other than 
the total amount of fluoride applied affected the fluoride concentration found 
in saliva. Despite this effort, statistical analysis showed that the amount of 
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Vanish applied was significantly less than that of the other products. This 
finding was not a surprise to the operator as it was noted in some early trial 
runs that in addition to color and odor differences, the high viscosity of 
Vanish made it more difficult to remove from the product container and 
application brush in comparison to the other varnishes. When the difference 
in amount of varnish applied was used as a covariate in the analysis of 
varnish and time effects on salivary fluoride levels, it was not found to have 
a significant influence on the results.  
Although differences in previous study designs make direct 
comparisons to the current study difficult, the studies conducted by Seppä14 
and Twetman15 allow for some comparisons. In both these studies, Duraphat 
5% NaF was used, whole unstimulated saliva was collected at various time 
intervals, and the samples were centrifuged prior to analysis. While the one 
hour time period mean salivary fluoride in the current study was found to be 
18.94 (±9.95) ppm, Twetman and Seppä's were 13.37(±4.70), and 12.37 
(±4.34) respectively at the same time period. While this difference may not 
appear large, Twetman applied nearly twice as much (0.75 ml) Duraphat 
than in the current study (0.4 ml). It would seem reasonable that Twetman 
should have recorded significantly higher one hour time period salivary 
fluoride levels than in the current study, however study design differences, 
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such as the application technique, post application instructions, and 
population, may explain these differences. Twetman applied fluoride to all 
surfaces of the teeth, including the occlusal. He did not dictate any pre or 
post application avoidance of food or drink, and his population consisted of 
school aged children. In contrast, the current study dictated that subjects 
refrain from eating or drinking one hour prior to collection times, which 
meant that after initial application subjects did not have any food or drink 
before the 1 hour collection time period. Additionally, in the current study, 
the varnish was only applied to the buccal surfaces of teeth in adults. By 
applying varnish to the occlusal surfaces of school aged children and 
allowing for post application eating and drinking, a large portion of the 
varnish may have abraded or dissolved away by the one hour time period 
accounting for the unexpectedly lower fluoride levels (considering the 
relatively high amount of product application) at the one hour time period of 
Twetman’s study. Seppä reported applying nearly similar amounts of 
Duraphat as the current study (0.5 ml vs. 0.4 ml), however she did not report 
using any form of isolation during application. As a result, the lower amount 
of fluoride in saliva at the 1 hour time period may have been from early 
ingestion or inadvertent application of varnish on the soft tissues.  
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The mean ppm of fluoride in saliva for the individual varnishes over 
time demonstrates that the overall pattern of fluoride release among the 
products was very similar. The highest fluoride concentration in saliva was 
seen for all the products in the first collection period after application (1 
hour) and the fluoride concentration in saliva began to decline after this at 
each subsequent collection period. This finding, which supports the 
secondary null hypothesis, is consistent with the findings by other authors 
that have found a peak in salivary fluoride levels within minutes of 
application followed by a steady decrease.12,14,15 Although the logistics of 
this study prevented saliva collection minutes after application, it is likely, 
based on the study by Eakle et al.,12  that the 1 hour salivary fluoride 
concentration in this study represents a point on the declination of the ppm 
curve. Eakle et al. measured peak levels of fluoride in saliva five to fifteen 
minutes after fluoride application, which was not evaluated in this study. 
Although it has been demonstrated that fluoride can be stored in soft 
and hard oral tissues as well as dental plaque,16,17 it is presumed that saliva 
represents the initial medium into which fluoride is released. The relative 
ease of collection and measurement make saliva a great candidate for in vivo 
fluoride release studies; however fluoride activity likely continues long after 
the 50 hours it was measurable in saliva. One assumption that has been made 
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when conducting salivary fluoride concentration studies is that the 
distribution of fluoride released in saliva to other oral tissues and plaque is 
similar. As future studies begin to demonstrate the complexity of these 
products and their reactions in biological systems, we may find that the 
distribution of fluoride to enamel, soft tissue, plaque, etc. differs among 
varnishes.  
 In addition to the portion of fluoride that potentially becomes bound 
to other oral structures or plaque, in vivo studies involving saliva also are 
complicated by the fact that the medium is constantly being ingested. In 
vitro, it is possible to evaluate total fluoride release from the products 
because the fluoride is released into a closed system (artificial saliva). 
Because the total fluoride release in vivo cannot be accounted for, we cannot 
conclude that Enamel Pro releases less fluoride, we can only conclude 
within the limitations of this study that the amount of fluoride released into 
saliva is less for subjects treated with Enamel Pro. If the distribution of 
fluoride to other oral tissues and plaque are directly related to salivary 
fluoride levels, this lesser amount of release from Enamel Pro may diminish 
its potential efficacy as a topical fluoride agent, however this requires further 
evaluation. 
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 Differences in viscosity, which was a subjective finding in this study, 
may be one of many differences in physical properties of interest when 
evaluating fluoride release from varnishes in vivo. Abrasion resistance, 
solubility, adhesion, etc. may also account for differences between the in 
vivo and in vitro results. Teeth are undoubtedly subjected to many 
mechanical forces unaccounted for in laboratory studies that may affect the 
retention and subsequent release of fluoride into saliva. It is possible that 
although Enamel Pro has the potential to release more fluoride as 
demonstrated in vitro, it was mechanically unable to withstand the oral 
environment as well as the other varnishes and therefore was dissociated 
from the teeth and swallowed before reaching this potential.  
 It is important to appreciate that before any conclusions regarding the 
efficacy between different fluoride varnishes can be made, several future 
investigations must be considered. Only by accounting for the total amount 
of fluoride released in vivo, by both systemic fluoride measurements after 
varnish application and measurements of levels in soft tissue, hard tissue, 
plaque etc., can true comparisons of fluoride release between products be 
made. Chemical, physical, and mechanical properties studies may also help 
to determine if there is a link between the total fluoride release and particular 
properties of the varnish. These types of studies, paired with studies further 
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evaluating the mechanism of action of topical fluoride, may advance our 
understanding of varnish efficacy.   
Conclusions 
From this study which evaluated the fluoride concentration of saliva after the 
application of three different 5% NaF varnishes, the following conclusions 
can be made: 
 
1. Despite similar concentrations of fluoride, the amount of fluoride 
released into saliva from Enamel Pro is significantly less than that of 
Vanish or Duraphat up to 26 hours after application.  
 
2. Vanish and Duraphat release similar amounts of fluoride up to 26 
hours, but Duraphat sustains a higher release than Vanish up to 50 
hours after application. 
 
3. All three varnishes maintain above baseline salivary fluoride levels up 
to 6 hours.  
 
4. Duraphat and Vanish maintain above baseline salivary fluoride levels 
up to 26 hours, although Vanish was not significant due to a higher 
standard deviation.  
 
5. Enamel Pro, Vanish, and Duraphat release the maximum amount of 
fluoride into saliva after application and the levels decrease at each 
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